The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are ...

Allworth Financial LP boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 36.9% during the fourth quarter, according to its most recent 13F filing with the ...

To the extent it does matter though, the iShares S&P 500 Growth ETF is a better-balanced fund than comparable alternatives, ...

US Bancorp DE lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,602 ...

Earlier this week, the Trump administration froze and then rescinded the freeze on federal funding for several programs, including research funding that the biotech ... and in the ETF space.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

The iShares Core S&P 500 ETF provides simple access to 500 top U.S. stocks via one investment. It has a low expense ratio of 0.03%, making it a very affordable way to track the S&P 500.

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.